INS and type 1 diabetes mellitus: Notably, in type 1 diabetes, while the quantitative relationship between glycemic variability and microvascular complications requires larger validation studies, closed‐loop insulin systems that reduce glucose fluctuations improve nerve conduction velocity by 23% (p < 0.05), underscoring the therapeutic value of variability control (Smith‐Palmer et al. 2014).